Goat anti-Human IgE (Chain epsilon) Antibody (DyLight 800)
Quick Overview for Goat anti-Human IgE (Chain epsilon) Antibody (DyLight 800) (ABIN612003)
Target
Clonality
Conjugate
-
-
Binding Specificity
- Chain epsilon
-
Reactivity
- Human
-
Host
- Goat
-
Purpose
- Goat anti-Human IgE (iμ chain) - Affinity Pure, DyLight ®800 Conjugate
-
Specificity
- Based on IEP, this antibody reacts with: • heavy (iμ) chains on human IgE
-
Cross-Reactivity (Details)
- Based on IEP, no reactivity is observed to: • non-immunoglobulin human serum immunoglobulins • light chains on all human immunoglobulins
-
Purification
- Affinity purified using solid phase Human IgE
-
Purity
- Affinity purified antibody is > 95 % based on SDS-PAGE. E 1 % at 280 nm = 13.0
-
Immunogen
- Purified Human IgE, (imu) chain
-
-
-
-
Comment
-
Country of Origin: Goat serum was obtained from healthy animals of US origin, under the care of a registered veterinarian.
DyLight is a trademark of Thermo Fisher Scientific, Inc. and its subsidiaries. -
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Rehydrate with 1.1 mL of deionized water and let stand 30 minutes at room temperature to dissolve. (Product has been overfilled to ensure complete recovery.) Centrifuge to remove any particulates. Prepare fresh working dilution daily.
-
Concentration
- 1.0 mg/mL
-
Buffer
- 10 mM Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2, 1 % (w/v) BSA, Protease/IgG free, contains 0.05 % (w/v) Sodium Azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Product is stable for up to 4 weeks at 2-8 °C after rehydration. For extended storage after rehydration, add an equal volume of glycerol and store at -20 °C.
-
Storage
- 4 °C
-
Storage Comment
- Store freeze-dried powder at 2-8 °C.
-
Expiry Date
- 4 weeks
-
-
- IgE
-
Background
- This antibody reacts with Human IgE (iμ chain). IgE evaluation of patients with suspected diseases associated with elevations in total immunoglobulin E (IgE), including allergic disease, primary immunodeficiencies, infections, malignancies, or other inflammatory diseases.
Target
-